Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Radius Health, Inc.RDUS · Entity 124173 | 10% owner | November 06, 2019 | November 08, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Radius Health, Inc.
Report date November 06, 2019 · Filed November 08, 2019
Jointly reported with BB BIOTECH AG
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,881,685 |
Reported balance
After 2019-11-06 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2019-11-06 · Purchase · Acquired 100,000 · Balance 6,881,685 |
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Black Diamond Therapeutics, Inc.
Report date March 19, 2025 · Filed March 21, 2025
Jointly reported with BB BIOTECH AG
Section 16 reporting ended · disclosed 2025-03-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,517,839 |
Reported balance
After 2025-03-19 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2025-03-19 · Sale · Disposed 1,000,000 · Balance 7,517,839 |
| Common StockSEC Table I · non-derivative | Direct | 7,217,839 |
Reported balance
After 2025-03-19 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2025-03-19 · Sale · Disposed 300,000 · Balance 7,217,839 |
| Common StockSEC Table I · non-derivative | Direct | 6,217,839 |
Reported balance
After 2025-03-19 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2025-03-19 · Sale · Disposed 1,000,000 · Balance 6,217,839 |
| Common StockSEC Table I · non-derivative | Direct | 4,217,839 |
Reported balance
After 2025-03-19 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2025-03-19 · Sale · Disposed 2,000,000 · Balance 4,217,839 |
| Common StockSEC Table I · non-derivative | Direct | 3,817,839 |
Reported balance
After 2025-03-19 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2025-03-19 · Sale · Disposed 400,000 · Balance 3,817,839 |
| Common StockSEC Table I · non-derivative | Direct | 3,233,547 |
Reported balance
After 2025-03-19 transaction · row 6
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 6 · 2025-03-19 · Sale · Disposed 584,292 · Balance 3,233,547 |
| Common StockSEC Table I · non-derivative | Direct | 2,733,547 |
Reported balance
After 2025-03-19 transaction · row 7
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 7 · 2025-03-19 · Sale · Disposed 500,000 · Balance 2,733,547 |
ESSA Pharma Inc.
Report date November 01, 2024 · Filed November 05, 2024
Jointly reported with BB BIOTECH AG
Section 16 reporting ended · disclosed 2024-11-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 5,879,583 |
Reported balance
After 2024-11-01 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2024-11-01 · Sale · Disposed 2,000,000 · Balance 5,879,583 |
| Common SharesSEC Table I · non-derivative | Direct | 3,879,583 |
Reported balance
After 2024-11-01 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2024-11-01 · Sale · Disposed 2,000,000 · Balance 3,879,583 |
| Common SharesSEC Table I · non-derivative | Direct | 1,879,583 |
Reported balance
After 2024-11-01 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2024-11-01 · Sale · Disposed 2,000,000 · Balance 1,879,583 |
| Common SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-11-01 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2024-11-01 · Sale · Disposed 1,879,583 · Balance 0 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 19, 2025 Filed Mar 21, 2025 01:01 UTC | Black Diamond Therapeutics, Inc. BDTX · Entity 6669 | SaleCommon Stock | 500,000 | $2.12 | $1,058,450.00 |
DisclosureSEC source: 0001104659-25-026305 · tm259930-1_4seq1.xml · nonDerivative · entry 7 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,733,547 Read SEC document |
| March 19, 2025 Filed Mar 21, 2025 01:01 UTC | Black Diamond Therapeutics, Inc. BDTX · Entity 6669 | SaleCommon Stock | 584,292 | $1.95 | $1,141,239.13 |
DisclosureSEC source: 0001104659-25-026305 · tm259930-1_4seq1.xml · nonDerivative · entry 6 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,233,547 Read SEC document |
| March 19, 2025 Filed Mar 21, 2025 01:01 UTC | Black Diamond Therapeutics, Inc. BDTX · Entity 6669 | SaleCommon Stock | 400,000 | $2.09 | $837,160.00 |
DisclosureSEC source: 0001104659-25-026305 · tm259930-1_4seq1.xml · nonDerivative · entry 5 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,817,839 Read SEC document |
| March 19, 2025 Filed Mar 21, 2025 01:01 UTC | Black Diamond Therapeutics, Inc. BDTX · Entity 6669 | SaleCommon Stock | 2,000,000 | $2.00 | $4,000,800.00 |
DisclosureSEC source: 0001104659-25-026305 · tm259930-1_4seq1.xml · nonDerivative · entry 4 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,217,839 Read SEC document |
| March 19, 2025 Filed Mar 21, 2025 01:01 UTC | Black Diamond Therapeutics, Inc. BDTX · Entity 6669 | SaleCommon Stock | 1,000,000 | $2.31 | $2,308,100.00 |
DisclosureSEC source: 0001104659-25-026305 · tm259930-1_4seq1.xml · nonDerivative · entry 3 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,217,839 Read SEC document |
| March 19, 2025 Filed Mar 21, 2025 01:01 UTC | Black Diamond Therapeutics, Inc. BDTX · Entity 6669 | SaleCommon Stock | 300,000 | $1.94 | $582,900.00 |
DisclosureSEC source: 0001104659-25-026305 · tm259930-1_4seq1.xml · nonDerivative · entry 2 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,217,839 Read SEC document |
| March 19, 2025 Filed Mar 21, 2025 01:01 UTC | Black Diamond Therapeutics, Inc. BDTX · Entity 6669 | SaleCommon Stock | 1,000,000 | $2.07 | $2,069,100.00 |
DisclosureSEC source: 0001104659-25-026305 · tm259930-1_4seq1.xml · nonDerivative · entry 1 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,517,839 Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 17:06 UTC | ESSA Pharma Inc. EPIX · Entity 15763 | SaleCommon Shares | 1,879,583 | $1.51 | $2,843,809.08 |
DisclosureSEC source: 0000950170-24-121206 · ownership.xml · nonDerivative · entry 4 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 17:06 UTC | ESSA Pharma Inc. EPIX · Entity 15763 | SaleCommon Shares | 2,000,000 | $1.53 | $3,058,800.00 |
DisclosureSEC source: 0000950170-24-121206 · ownership.xml · nonDerivative · entry 3 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,879,583 Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 17:06 UTC | ESSA Pharma Inc. EPIX · Entity 15763 | SaleCommon Shares | 2,000,000 | $1.53 | $3,051,800.00 |
DisclosureSEC source: 0000950170-24-121206 · ownership.xml · nonDerivative · entry 2 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,879,583 Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 17:06 UTC | ESSA Pharma Inc. EPIX · Entity 15763 | SaleCommon Shares | 2,000,000 | $1.53 | $3,064,000.00 |
DisclosureSEC source: 0000950170-24-121206 · ownership.xml · nonDerivative · entry 1 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,879,583 Read SEC document |
| October 17, 2023 Filed Oct 19, 2023 19:08 UTC | Black Diamond Therapeutics, Inc. BDTX · Entity 6669 | PurchaseCommon Stock | 400,000 | $2.34 | $934,080.00 |
DisclosureSEC source: 0000950170-23-054142 · ownership.xml · nonDerivative · entry 1 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,517,839 Read SEC document |
| June 30, 2023 Filed Jul 3, 2023 19:36 UTC | Black Diamond Therapeutics, Inc. BDTX · Entity 6669 | PurchaseCommon Stock | 1,000,000 | $5.00 | $5,000,000.00 |
DisclosureSEC source: 0000950170-23-031386 · ownership.xml · nonDerivative · entry 1 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,117,839 Read SEC document |
| June 27, 2023 Filed Jun 29, 2023 17:37 UTC | Black Diamond Therapeutics, Inc. BDTX · Entity 6669 | PurchaseCommon Stock | 1,740,000 | $5.49 | $9,555,036.00 |
DisclosureSEC source: 0000899243-23-016705 · doc4.xml · nonDerivative · entry 1 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,117,839 Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 19:10 UTC | Black Diamond Therapeutics, Inc. BDTX · Entity 6669 | PurchaseCommon Stock | 99,801 | $2.25 | $224,911.53 |
DisclosureSEC source: 0000899243-22-034751 · doc4.xml · nonDerivative · entry 1 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,377,839 Read SEC document |
| October 28, 2022 Filed Oct 31, 2022 19:20 UTC | Black Diamond Therapeutics, Inc. BDTX · Entity 6669 | PurchaseCommon Stock | 172,974 | $2.18 | $376,962.24 |
DisclosureSEC source: 0000899243-22-034543 · doc4.xml · nonDerivative · entry 2 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,278,038 Read SEC document |
| October 27, 2022 Filed Oct 28, 2022 18:57 UTC | ESSA Pharma Inc. EPIX · Entity 15763 | PurchaseCommon Shares | 500,000 | $4.50 | $2,251,100.00 |
DisclosureSEC source: 0000899243-22-034401 · doc4.xml · nonDerivative · entry 2 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,879,583 Read SEC document |
| October 27, 2022 Filed Oct 31, 2022 19:20 UTC | Black Diamond Therapeutics, Inc. BDTX · Entity 6669 | PurchaseCommon Stock | 191,678 | $1.87 | $359,223.74 |
DisclosureSEC source: 0000899243-22-034543 · doc4.xml · nonDerivative · entry 1 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,105,064 Read SEC document |
| October 26, 2022 Filed Oct 28, 2022 18:57 UTC | ESSA Pharma Inc. EPIX · Entity 15763 | PurchaseCommon Shares | 1,500,000 | $3.98 | $5,968,500.00 |
DisclosureSEC source: 0000899243-22-034401 · doc4.xml · nonDerivative · entry 1 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,379,583 Read SEC document |
| October 21, 2022 Filed Oct 25, 2022 20:24 UTC | Black Diamond Therapeutics, Inc. BDTX · Entity 6669 | PurchaseCommon Stock | 87,850 | $1.51 | $132,750.14 |
DisclosureSEC source: 0000899243-22-034121 · doc4.xml · nonDerivative · entry 1 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,913,386 Read SEC document |
| October 20, 2022 Filed Oct 21, 2022 19:06 UTC | Black Diamond Therapeutics, Inc. BDTX · Entity 6669 | PurchaseCommon Stock | 53,734 | $1.42 | $76,345.27 |
DisclosureSEC source: 0000899243-22-033945 · doc4.xml · nonDerivative · entry 2 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,825,536 Read SEC document |
| October 19, 2022 Filed Oct 21, 2022 19:06 UTC | Black Diamond Therapeutics, Inc. BDTX · Entity 6669 | PurchaseCommon Stock | 77,689 | $1.32 | $102,774.78 |
DisclosureSEC source: 0000899243-22-033945 · doc4.xml · nonDerivative · entry 1 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,771,802 Read SEC document |
| July 18, 2022 Filed Jul 20, 2022 19:21 UTC | ESSA Pharma Inc. EPIX · Entity 15763 | PurchaseCommon Shares | 300,000 | $3.16 | $946,740.00 |
DisclosureSEC source: 0000899243-22-026410 · doc4.xml · nonDerivative · entry 1 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,879,583 Read SEC document |
| July 15, 2022 Filed Jul 18, 2022 16:48 UTC | ESSA Pharma Inc. EPIX · Entity 15763 | PurchaseCommon Shares | 241,665 | $3.13 | $756,798.11 |
DisclosureSEC source: 0000899243-22-026225 · doc4.xml · nonDerivative · entry 2 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,579,583 Read SEC document |
| July 14, 2022 Filed Jul 18, 2022 16:48 UTC | ESSA Pharma Inc. EPIX · Entity 15763 | PurchaseCommon Shares | 347,204 | $2.79 | $969,428.29 |
DisclosureSEC source: 0000899243-22-026225 · doc4.xml · nonDerivative · entry 1 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,337,918 Read SEC document |
| April 28, 2022 Filed Apr 29, 2022 14:50 UTC | Black Diamond Therapeutics, Inc. BDTX · Entity 6669 | PurchaseCommon Stock | 255,711 | $2.57 | $657,867.69 |
DisclosureSEC source: 0000899243-22-016006 · doc4.xml · nonDerivative · entry 2 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,694,113 Read SEC document |
| April 27, 2022 Filed Apr 28, 2022 16:28 UTC | ESSA Pharma Inc. EPIX · Entity 15763 | SaleCommon Shares | 25,100 | $5.85 | $146,925.36 |
DisclosureSEC source: 0000899243-22-015831 · doc4.xml · nonDerivative · entry 1 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,990,714 Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 14:50 UTC | Black Diamond Therapeutics, Inc. BDTX · Entity 6669 | PurchaseCommon Stock | 150,000 | $2.66 | $399,480.00 |
DisclosureSEC source: 0000899243-22-016006 · doc4.xml · nonDerivative · entry 1 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,438,402 Read SEC document |
| April 19, 2022 Filed Apr 20, 2022 16:56 UTC | Black Diamond Therapeutics, Inc. BDTX · Entity 6669 | PurchaseCommon Stock | 150,000 | $3.24 | $486,645.00 |
DisclosureSEC source: 0000899243-22-015145 · doc4.xml · nonDerivative · entry 2 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,288,402 Read SEC document |
| April 18, 2022 Filed Apr 20, 2022 16:56 UTC | Black Diamond Therapeutics, Inc. BDTX · Entity 6669 | PurchaseCommon Stock | 150,000 | $3.29 | $493,935.00 |
DisclosureSEC source: 0000899243-22-015145 · doc4.xml · nonDerivative · entry 1 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,138,402 Read SEC document |
| April 13, 2022 Filed Apr 14, 2022 16:09 UTC | Black Diamond Therapeutics, Inc. BDTX · Entity 6669 | PurchaseCommon Stock | 102,556 | $3.57 | $366,217.22 |
DisclosureSEC source: 0000899243-22-014768 · doc4.xml · nonDerivative · entry 2 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,988,402 Read SEC document |
| April 12, 2022 Filed Apr 14, 2022 16:09 UTC | Black Diamond Therapeutics, Inc. BDTX · Entity 6669 | PurchaseCommon Stock | 150,000 | $3.42 | $513,600.00 |
DisclosureSEC source: 0000899243-22-014768 · doc4.xml · nonDerivative · entry 1 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,885,846 Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 16:43 UTC | ESSA Pharma Inc. EPIX · Entity 15763 | PurchaseCommon Shares | 250,000 | $8.88 | $2,218,800.00 |
DisclosureSEC source: 0000899243-21-033765 · doc4.xml · nonDerivative · entry 1 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,015,814 Read SEC document |
| November 06, 2019 Filed Nov 8, 2019 19:52 UTC | Radius Health, Inc. RDUS · Entity 124173 | PurchaseCommon Stock | 100,000 | $23.00 | $2,300,300.00 |
DisclosureSEC source: 0000899243-19-026963 · doc4.xml · nonDerivative · entry 1 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,881,685 Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 16:04 UTC | Radius Health, Inc. RDUS · Entity 124173 | OtherCommon Stock Warrant (right to buy) · Derivative | 71,409 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0000899243-19-003965 · doc4.xml · derivative · entry 2 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 71,409 shares Expires 2014-02-19 Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 16:04 UTC | Radius Health, Inc. RDUS · Entity 124173 | OtherCommon Stock | 71,409 | $14.00 | $1,000,011.64 |
DisclosureSEC source: 0000899243-19-003965 · doc4.xml · nonDerivative · entry 1 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,781,685 Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 17:00 UTC | Radius Health, Inc. RDUS · Entity 124173 | PurchaseCommon Stock | 60,000 | $14.48 | $868,782.00 |
DisclosureSEC source: 0000899243-18-031549 · doc4.xml · nonDerivative · entry 1 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,710,276 Read SEC document |
| December 14, 2018 Filed Dec 17, 2018 20:35 UTC | Radius Health, Inc. RDUS · Entity 124173 | PurchaseCommon Stock | 60,000 | $15.64 | $938,256.00 |
DisclosureSEC source: 0000899243-18-031191 · doc4.xml · nonDerivative · entry 1 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,650,276 Read SEC document |
| August 20, 2018 Filed Aug 22, 2018 15:08 UTC | Radius Health, Inc. RDUS · Entity 124173 | PurchaseCommon Stock | 60,000 | $19.65 | $1,178,808.00 |
DisclosureSEC source: 0000899243-18-022966 · doc4.xml · nonDerivative · entry 1 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,590,276 Read SEC document |
| August 15, 2018 Filed Aug 16, 2018 19:18 UTC | Radius Health, Inc. RDUS · Entity 124173 | PurchaseCommon Stock | 69,363 | $20.78 | $1,441,529.61 |
DisclosureSEC source: 0000899243-18-022543 · doc4.xml · nonDerivative · entry 2 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,530,276 Read SEC document |
| August 14, 2018 Filed Aug 16, 2018 19:18 UTC | Radius Health, Inc. RDUS · Entity 124173 | PurchaseCommon Stock | 100,000 | $20.87 | $2,086,880.00 |
DisclosureSEC source: 0000899243-18-022543 · doc4.xml · nonDerivative · entry 1 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,460,913 Read SEC document |
| August 08, 2018 Filed Aug 10, 2018 19:04 UTC | Radius Health, Inc. RDUS · Entity 124173 | PurchaseCommon Stock | 60,000 | $22.73 | $1,363,884.00 |
DisclosureSEC source: 0000899243-18-022027 · doc4.xml · nonDerivative · entry 1 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,360,913 Read SEC document |
| July 27, 2018 Filed Jul 30, 2018 21:23 UTC | Radius Health, Inc. RDUS · Entity 124173 | PurchaseCommon Stock | 50,000 | $24.81 | $1,240,605.00 |
DisclosureSEC source: 0000899243-18-020772 · doc4.xml · nonDerivative · entry 1 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,300,913 Read SEC document |
| July 25, 2018 Filed Jul 26, 2018 18:56 UTC | Radius Health, Inc. RDUS · Entity 124173 | PurchaseCommon Stock | 50,000 | $27.28 | $1,363,805.00 |
DisclosureSEC source: 0000899243-18-020649 · doc4.xml · nonDerivative · entry 1 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250,913 Read SEC document |
| June 11, 2018 Filed Jun 13, 2018 19:29 UTC | Radius Health, Inc. RDUS · Entity 124173 | PurchaseCommon Stock | 50,000 | $27.36 | $1,367,835.00 |
DisclosureSEC source: 0000899243-18-016344 · doc4.xml · nonDerivative · entry 1 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,200,913 Read SEC document |
| May 23, 2018 Filed May 24, 2018 18:29 UTC | Radius Health, Inc. RDUS · Entity 124173 | PurchaseCommon Stock | 40,000 | $28.91 | $1,156,320.00 |
DisclosureSEC source: 0000899243-18-013884 · doc4.xml · nonDerivative · entry 1 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,150,913 Read SEC document |
| May 21, 2018 Filed May 23, 2018 18:42 UTC | Radius Health, Inc. RDUS · Entity 124173 | PurchaseCommon Stock | 60,000 | $29.27 | $1,756,380.00 |
DisclosureSEC source: 0000899243-18-013810 · doc4.xml · nonDerivative · entry 1 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,110,913 Read SEC document |
| April 19, 2018 Filed Apr 23, 2018 17:28 UTC | Radius Health, Inc. RDUS · Entity 124173 | PurchaseCommon Stock | 40,000 | $33.80 | $1,351,936.00 |
DisclosureSEC source: 0000899243-18-010551 · doc4.xml · nonDerivative · entry 1 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,050,913 Read SEC document |
| April 12, 2018 Filed Apr 16, 2018 18:07 UTC | Radius Health, Inc. RDUS · Entity 124173 | OtherCommon Stock Warrant (right to buy) · Derivative | 107,114 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0000899243-18-010183 · doc4.xml · derivative · entry 2 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,409 Underlying: Common Stock · 107,114 shares Expires 2018-04-23 Read SEC document |
| April 12, 2018 Filed Apr 16, 2018 18:07 UTC | Radius Health, Inc. RDUS · Entity 124173 | OtherCommon Stock | 107,114 | $14.00 | $1,500,024.46 |
DisclosureSEC source: 0000899243-18-010183 · doc4.xml · nonDerivative · entry 1 BIOTECH GROWTH N V · CIK 0001259869 · 10% owner BB BIOTECH AG · CIK 0000924223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,010,913 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.